Holland Cynthia L, Rubio Doris, Rodriguez Keri L, Kraemer Kevin L, Day Nancy, Arnold Robert M, Tarr Jill A, Chang Judy C
Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Women's Research Institute, the Division of General Internal Medicine, Department of Internal Medicine, Center for Research in Health Care, Clinical and Translational Science Institute, University of Pittsburgh, the Center for Health Equity Research & Promotion, Veterans Affairs Pittsburgh Healthcare System, the Department of Psychiatry, University of Pittsburgh, and the Section of Palliative Care and Medical Ethics, Institute to Enhance Palliative Care, Institute for Doctor-Patient Communication, Center for Research in Health Care, Pittsburgh, Pennsylvania.
Obstet Gynecol. 2016 Apr;127(4):681-687. doi: 10.1097/AOG.0000000000001343.
To describe obstetric health care providers' responses and counseling approaches to patients' disclosures of marijuana use during first prenatal visits.
We performed a content analysis of audio-recorded patient-health care provider first prenatal visits for obstetrics health care providers' responses to patients' disclosure of marijuana use. The study was conducted at five urban outpatient clinics located in Pittsburgh, Pennsylvania.
Among 468 audio-recorded first obstetric encounters, 90 patients (19%) disclosed marijuana use to 47 health care providers; mean number of recoded encounters containing marijuana disclosures for participating health providers was 1.8±1.4. In 48% of these 90 visits, obstetric health care providers did not respond to marijuana use disclosures or offer counseling. When counseling was offered, it consisted of general statements without specific information on the risks or outcomes related to marijuana use in pregnancy, discussions regarding the need for urine toxicology testing, and warnings that use detected at the time of delivery would initiate child protective services involvement.
Obstetric health care provider responses to disclosure of marijuana use occurred in approximately half of patient encounters when marijuana use was disclosed and focused on legal and procedural consequences with less focus on health or medical implications. Our results suggest a need for health care provider training on potential consequences of perinatal marijuana use and communication skills for counseling patients about perinatal marijuana.
描述产科保健提供者对患者在首次产前检查时披露使用大麻情况的反应及咨询方式。
我们对产科保健提供者对患者披露使用大麻情况的首次产前检查进行了录音,并对其进行内容分析。该研究在宾夕法尼亚州匹兹堡的五家城市门诊诊所进行。
在468次首次产科检查的录音中,90名患者(19%)向47名保健提供者披露了使用大麻的情况;参与研究的保健提供者记录的包含大麻披露的检查平均次数为1.8±1.4次。在这90次就诊中,48%的情况下,产科保健提供者未对大麻使用披露做出回应或提供咨询。当提供咨询时,内容包括一般性陈述,没有关于孕期使用大麻相关风险或后果的具体信息,讨论尿液毒理学检测的必要性,以及警告在分娩时检测到使用大麻将导致儿童保护服务介入。
当患者披露使用大麻情况时,产科保健提供者约有一半的情况下会做出反应,且重点关注法律和程序后果,而较少关注健康或医学影响。我们的结果表明,需要对保健提供者进行围产期使用大麻潜在后果的培训,以及关于为患者提供围产期大麻咨询的沟通技巧培训。